Blog

Contract Development and Manufacturing Organizations (CDMOs) are no longer just “overflow plants” for big pharma. The sector is undergoing a rapid transformation, where capital flows, new therapeutic modalities, and advanced delivery technologies are converging to.

The contract development and manufacturing organization (CDMO) landscape is shifting faster than ever. What once revolved around reliable production capacity now sits at the intersection of physical infrastructure, digital transformation, and forward-thinking leadership. Together, these forces.

Most people picture chemical manufacturing as lab coats, test tubes, and complex formulas scrawled on whiteboards.But in reality, it’s the quiet, relentless engine behind everything from the food we eat to the tech in our.

July 29, 2025 – The new EU–US trade deal could add $13–$19 billion in costs to the pharmaceutical industry as branded European medicines face a 15% import tariff when sold in the United States. Pharmaceuticals have historically been tariff‑free, but.

The U.S. biomanufacturing landscape is shifting—and antibody-drug conjugates (ADCs) are at the center of the movement. With Simtra BioPharma’s recent acquisition of a 65-acre site in Bloomington, Indiana, the company is set to become the first.

How UK–Vietnam Collaboration is Shaping a New Era for Pharma Manufacturing and Exports In a significant move for the life sciences and pharmaceutical sector, recent UK–Vietnam trade agreements are poised to accelerate drug approvals, enhance.

Why supply chain proximity is becoming a competitive edge for CDMO partnerships The pharmaceutical industry is undergoing a structural pivot—one that’s not just about efficiency or cost, but about control, resilience, and strategic alignment. While globalization.

The pharmaceutical manufacturing landscape is entering a new era — one defined by predictive capabilities, adaptive processes, and real-time data feedback loops. At the center of this evolution are three key technologies that are gaining serious momentum in.

The Rise of Continuous Manufacturing and Oral GLP‑1 Scale-Up The pharmaceutical manufacturing landscape is undergoing a rapid evolution. As drug pipelines become more specialized and demand more precision, CDMOs (Contract Development and Manufacturing Organizations) are.

As geopolitical pressure builds, contract development and manufacturing organizations (CDMOs) in China are being forced to rethink how—and where—they operate. With U.S.–China relations growing increasingly strained, CDMOs like WuXi AppTec and WuXi Biologics are taking.

In a pharmaceutical world increasingly captivated by biologics, cell and gene therapies, and mRNA platforms, small molecule drugs have spent the last few years in the shadow of the new. But quietly—strategically—they’ve been staging a.

The CDMO recovery in 2025 is gaining momentum. After a challenging period marked by overcapacity and clinical delays, the contract development and manufacturing organization (CDMO) sector is beginning to bounce back.

As the chemical industry continues to transform, talent needs are evolving just as fast as the technologies. Companies are no longer just looking for specialists—they’re seeking agile, multi-dimensional professionals who can drive innovation, meet regulatory.

Green chemistry isn’t just a buzzword anymore. It’s becoming a strategic pillar, especially for Contract Development and Manufacturing Organizations (CDMOs) who want to stay competitive and compliant. But let’s cut through the noise. Is this really about.

For years, biologics have soaked up the spotlight—hailed as the future of medicine. But quietly, small molecules have been building a serious case for a comeback. And if you’re in the CDMO (Contract Development and.

What today’s hiring managers are really looking for in commercial leadership roles In the world of chemical manufacturing and distribution, technical expertise alone doesn’t close deals. As the industry grows more global, more specialized, and.

In the competitive world of chemical sales, finding standout business development professionals is no easy task. These roles require more than just charisma—they demand deep technical knowledge, a strategic mindset, and the ability to build.

The chemical industry has always been a dynamic force behind countless innovations, but 2025 marks a particularly pivotal year. From the rapid adoption of cutting-edge technology to bold sustainability targets, the landscape is evolving—and so.

In the life sciences industry, understanding the differences between contract and permanent roles is essential for both job seekers and employers. Each type of employment offers distinct advantages and considerations, making it crucial to assess.

The biotech industry is at the forefront of innovation and scientific advancement, but it also faces unique hiring challenges that can complicate the recruitment process. From talent shortages to the complexities of specialised skill sets,.

Navigating a job interview in the life sciences sector can be a daunting task, especially given the complexity and specificity of roles within this industry. However, asking insightful questions during the interview not only demonstrates.

In the competitive landscape of the life sciences industry, attracting and retaining top talent requires more than just offering attractive salaries and benefits. Developing a strong employer brand is essential for life science companies looking.

Hiring international talent in the life sciences industry offers significant benefits for companies looking to stay competitive and innovative. In a field that thrives on new ideas, diverse perspectives, and specialised skills, expanding your recruitment.

Navigating a career transition in the life sciences industry requires careful planning, flexibility, and the right strategies. Whether you’re a recent graduate seeking your first role or a seasoned professional exploring new challenges, moving within.